Western blot results showed that the expressions of fibronectin, collagen I, and α-SMA in the BLM group were significantly higher than those in the control group, and the expressions of these proteins were effectively inhibited after SIN treatment (Fig. 3A, B). The gene discussed is ACTA1; the disease is Bloom syndrome.